瑞士EffRx Pharmaceuticals
EffRx Pharmaceuticals SA是一家從事藥物釋放的公司,總部位于瑞士Freienbach。該公司利用其不同的泡騰實施創新技術,專長于改進現有的高容量藥物產品。EffRx的主要工作重心放在代謝性骨病、腫瘤支持治療、兒童用藥領域,并為大型生命周期管理(Life Cycle Management)公司提供支持。
EffRx已與Takeda旗下的奈科明公司(Nycomed)達成授權協議,在除美國、加拿大和日本之外的全球范圍開發、制造和商業化EffRx用于治療骨質疏松的專利泡騰阿侖膦酸鈉。
EffRx Pharmaceuticals SA is a drug delivery company based in Freienbach, Switzerland. EffRx specializes in improving existing high volume pharmaceutical products by utilizing its novel techniques in different effervescent executions. The primary focus of EffRx is in metabolic bone disease, oncology supportive care, pediatric medications and support to larger companies in Life Cycle Management.
EffRx has a licensing agreement with Nycomed, a Takeda Company, for development, manufacturing and commercialization of EffRx patented effervescent alendronate for the treatment of osteoporosis in all territories in the world except USA, Canada and Japan.